Polycythemia Vera Clinical Trials

180 clinical trials for Polycythemia Vera across international registries, including 34 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Phase IIa Study of Flonoltinib Maleate Tablets in the Treatment of Patients With Polycythemia Vera — RECRUITING · PHASE2
• A Randomized Study of ASTX727 With or Without Iadademstat in Advanced Myeloproliferative Neoplasms (MPNs) — RECRUITING · PHASE2
• Functional and Phenotypic Characterization of Monocytes in Myeloproliferative Syndromes — RECRUITING · NA
• A Study of Rusfertide in Japanese Adults With Polycythemia Vera — RECRUITING · PHASE2
• A Phase 1 Study of PRT12396 in Participants With Select Myeloproliferative Neoplasms — RECRUITING · PHASE1
• Observational Study on the Use of Ropeginterferon Alfa-2b in Polycythemia Vera (ROPEG-PV) — RECRUITING
• A ELN-Multicenter Study on Phenotypic Evolution and Clinical Outcomes — RECRUITING
• INTREPID: A Study of Sapablursen Evaluating the Safety and Efficacy in Participants With Polycythemia Vera (PV) — RECRUITING · PHASE3
• A Clinical Study of Gecacitinib Combined With Pegylated Interferon in Patients With PV — RECRUITING · NA
• MITHRIDATE: Ruxolitinib Versus Hydroxycarbamide or Interferon as First Line Therapy in High Risk Polycythemia Vera — RECRUITING · PHASE3
• A Study to Evaluate Safety and Efficacy of Bomedemstat (MK-3543-017) — RECRUITING · PHASE3
• Curcumin to Improve Inflammation and Symptoms in Patients With Clonal Cytopenia of Undetermined Significance, Low Risk Myelodysplastic Syndrome, and Myeloproliferative Neoplasms — RECRUITING · PHASE2
• Study on Efficacy and Safety of Givinostat Versus Hydroxyurea in Patients With Polycythemia Vera — RECRUITING · PHASE3
• AVAJAK: Apixaban/Rivaroxaban Versus Aspirin for Primary Prevention of Thrombo-embolic Complications in JAK2V617F-positive Myeloproliferative Neoplasms — RECRUITING · PHASE3
• Decitabine With Ruxolitinib, Fedratinib or Pacritinib for the Treatment of Accelerated/Blast Phase Myeloproliferative Neoplasms — RECRUITING · PHASE2
• An Optimal Dose Finding Study of N-Acetylcysteine in Patients With Myeloproliferative Neoplasms — RECRUITING · PHASE1
• MPN PROGRESSion Registry: Observational Study Tracking Symptoms, Treatments, and Disease Progression in People With Myeloproliferative Neoplasms (MPNs) — RECRUITING
• Ropeginterferon Alfa-2b in Patients With Polycythemia Vera (PV) Without Symptomatic Splenomegaly — RECRUITING
• Ruxolitinib in Thrombocythemia and Polycythemia Vera — RECRUITING · PHASE2
• MethoTRExATE in MyelOpRolifErative Neoplasms (TREATMORE) Trial — RECRUITING · PHASE2
• Two Step Haplo With Radiation Conditioning — RECRUITING · PHASE2
• A Study of GLB-001 in Patients With Myeloid Malignancies — RECRUITING · PHASE1
• A Study of Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of 9MW3011 in Patients With Polycythemia Vera — RECRUITING · PHASE1
• Efficacy and Safety of Peginterferon in ET and PV. — RECRUITING · NA
• Extension Study of P1101 After Completion of Phase 2 Study in PV Patients or Phase 3 Study in ET Patients — RECRUITING · PHASE3
• Myeloproliferative Neoplasms (MPNs) Patient Registry — RECRUITING
• Myeloproliferative Neoplastic Diseases Observatory From Brest — RECRUITING
• Pegylated Interferon α-2b in Combination With Ruxolitinib for Treating Hydroxyurea-resistant/Intolerant PV — RECRUITING · PHASE2
• AN OPEN LABEL, MULTI-CENTER, PHASE IV ROLLOVER PROTOCOL FOR PATIENTS WHO HAVE COMPLETED A PRIOR GLOBAL NOVARTIS OR INCYTE SPONSORED RUXOLITINIB (INC424) STUDY OR A STUDY OF RUXOLITINIB IN COMBINATION EITHER WITH PANOBINOSTAT (LBH589) OR SIREMADLIN (HDM201) OR RINETERKIB (LTT462), AND ARE JUDGED BY THE INVESTIGATOR TO BENEFIT FROM CONTINUED TREATMENT — RECRUITING · PHASE4
• Pacritinib w/ Talazoparib in Pts w/ Myeloproliferative Neoplasms Unresponsive to JAK2 Inhibition — RECRUITING · PHASE1
• Asian Myeloproliferative Neoplasm (MPN) Registry — RECRUITING
• A PHASE IIIB, SINGLE-ARM, MULTICENTER STUDY TO ACCESS EFFICACY, SAFETY, AND TOLERABILITY OF ROPEGINTERFERON ALFA-2B-NJFT (P1101) IN ADULT PATIENTS WITH POLYCYTHEMIA VERA (PV) — RECRUITING · PHASE3
• A PHASE 3 STUDY OF THE HEPCIDIN MIMETIC RUSFERTIDE (PTG-300) IN PATIENTS WITH POLYCYTHEMIA VERA — RECRUITING · PHASE3
• A PHASE 2, OPEN-LABEL, RANDOMIZED STUDY TO EVALUATE THE SAFETY AND EFFICACY OF MOMELOTINIB IN SUBJECTS WITH POLYCYTHEMIA VERA OR ESSENTIAL THROMBOCYTHEMIA — RECRUITING · PHASE2
• Randomized Polycythemia Vera Symptom Study comparing the effectiveness and patient assessed effects of Ruxolitinib with Hydroxyurea in a Phase 3 trial — COMPLETED · PHASE3
• International Study using Clopidogrel and Aspirin for the treatment of Polycythemia Vera. — COMPLETED · PHASE3
• A Study of Rusfertide in Adults With Polycythemia Vera in China — NOT_YET_RECRUITING · PHASE2
• The Ruxo-BEAT Trial in Patients With High-risk Polycythemia Vera or High-risk Essential Thrombocythemia — ACTIVE_NOT_RECRUITING · PHASE2
• A Phase 3 Study of the Hepcidin Mimetic Rusfertide (PTG-300) in Patients with Polycythemia Vera — TERMINATED · PHASE3
• A Phase 2, Open-Label Study of DISC-3405 in Participants With Polycythemia Vera (PV) — ACTIVE_NOT_RECRUITING · PHASE2
• Efficacy and Safety of Ropeginterferon Alfa 2b (P1101) for Patients With Polycythemia Vera — WITHDRAWN · PHASE4
• Standardized Documentation and Assessments for Polycythemia Vera: A Quality Improvement Initiative — NOT_YET_RECRUITING · NA
• A Clinical Trial of Bomedemstat in Participants With Polycythemia Vera (MK-3543-025) — NOT_YET_RECRUITING · PHASE2
• Azacitidine, Venetoclax, and Pevonedistat in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia — ACTIVE_NOT_RECRUITING · PHASE1
• LOW-PV Continuation — COMPLETED
• CINC424A2X01B Rollover Protocol — ACTIVE_NOT_RECRUITING · PHASE4
• Topotecan Hydrochloride and Carboplatin With or Without Veliparib in Treating Advanced Myeloproliferative Disorders and Acute Myeloid Leukemia or Chronic Myelomonocytic Leukemia — ACTIVE_NOT_RECRUITING · PHASE2
• Study to Identify and Describe Predictive Factors for Thromboembolic Events in Patients With High-risk Polycythemia Vera — ACTIVE_NOT_RECRUITING
• TGR-1202 + Ruxolitinib PMF PPV-MF PET-MF MDS/MPN Polycythemia Vera Resistant to Hydroxyurea — COMPLETED · PHASE1
• A Study of Bomedemstat (IMG-7289/MK-3543) in Participants With Polycythemia Vera (IMG-7289-CTP-203/MK-3543-004) — COMPLETED · PHASE2

Refine this search